GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Applied Molecular Transport Inc (NAS:AMTI) » Definitions » EPS (Diluted)

Applied Molecular Transport (Applied Molecular Transport) EPS (Diluted) : $-1.90 (TTM As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Applied Molecular Transport EPS (Diluted)?

Applied Molecular Transport's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was $-0.17. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.90.

Applied Molecular Transport's EPS (Basic) for the three months ended in Sep. 2023 was $-0.17. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.90.

Applied Molecular Transport's EPS without NRI for the three months ended in Sep. 2023 was $-0.17. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 was $-1.47.

During the past 3 years, the average EPS without NRIGrowth Rate was -35.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 5 years, Applied Molecular Transport's highest 3-Year average EPS without NRI Growth Rate was -16.30% per year. The lowest was -35.30% per year. And the median was -25.80% per year.


Applied Molecular Transport EPS (Diluted) Historical Data

The historical data trend for Applied Molecular Transport's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied Molecular Transport EPS (Diluted) Chart

Applied Molecular Transport Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
EPS (Diluted)
-1.70 -1.31 -2.91 -2.67 -3.25

Applied Molecular Transport Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.65 -0.58 -0.71 -0.44 -0.17

Competitive Comparison of Applied Molecular Transport's EPS (Diluted)

For the Biotechnology subindustry, Applied Molecular Transport's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied Molecular Transport's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Applied Molecular Transport's PE Ratio distribution charts can be found below:

* The bar in red indicates where Applied Molecular Transport's PE Ratio falls into.



Applied Molecular Transport EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Applied Molecular Transport's Diluted EPS for the fiscal year that ended in Dec. 2022 is calculated as

Diluted EPS (A: Dec. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-126.325-0)/38.837
=-3.25

Applied Molecular Transport's Diluted EPS for the quarter that ended in Sep. 2023 is calculated as

Diluted EPS (Q: Sep. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-6.937-0)/39.751
=-0.17

EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Applied Molecular Transport  (NAS:AMTI) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Applied Molecular Transport EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Applied Molecular Transport's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied Molecular Transport (Applied Molecular Transport) Business Description

Traded in Other Exchanges
N/A
Address
450 East Jamie Court, South San Francisco, CA, USA, 94080
Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.
Executives
Shawn Cross officer: Chief Financial Officer 1825 K STREET SUITE 510, WASHINGTON DC 20006
Mahmood Tahir Ph.d. director, officer: Chief Executive Officer 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Brandon Hants officer: VP, Finance & Bus. Ops. 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Douglas A. Rich officer: Chief Technical Officer C/O KYTHERA BIOPHARMACEUTICALS, INC., 30930 RUSSELL RANCH ROAD, 3RD FLOOR, WESTLAKE VILLAGE CA 91362
Bittoo Kanwar officer: Chief Medical Officer 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Mrsny Randall Ph.d. director, officer: Chief Scientific Officer 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
Aaron Vandevender director 1 TOWER PLACE, SUITE 850, SOUTH SAN FRANCISCO CA 94080
David Lamond director C/O CORTEXYME, INC., 269 EAST GRAND AVE., SOUTH SAN FRANCISCO CA 94080
Epiq Capital Group, Llc other: Managing member of 10% owner ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111
Chad Boeding other: CEO of Managing Member ONE LOMBARD STREET, SUITE 200, SAN FRANCISCO CA 94111
Charlene A. Banard director C/O APPLIED MOLECULAR TRANSPORT INC., 450 EAST JAMIE COURT, SOUTH SAN FRANCISCO CA 94080
John W Smither director C/O KYTHERA BIOPHARMACEUTICALS, INC., 27200 WEST AGOURA ROAD, SUITE 200, CALABASAS CA 91301
Epq Llc Amt Ps other: Owner 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521
Epq Llc, Amtc Ps other: Owner 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521
Epq Llc, Amtb Ps 10 percent owner 9650 GATEWAY DRIVE, SUITE 200, RENO NV 89521

Applied Molecular Transport (Applied Molecular Transport) Headlines

From GuruFocus

Applied Molecular Transport Provides Strategy Update

By GuruFocusNews GuruFocusNews 07-07-2022